First U.S. Patient Treated With BAGUERA®C Cervical Disc

First U.S. Patient Treated With BAGUERA®C Cervical Disc Prosthesis


Share this article
Share this article
LAGUNA HILLS, Calif., March 3, 2021 /PRNewswire/ -- Spineart USA Inc. announced today that clinical principal investigator, Dr. Domagoj Coric at Carolina Neurosurgery and Spine Associates in Charlotte NC, performed the first surgery in the two-level U.S. Investigational Device Exemption (IDE) Clinical Trial of the BAGUERA®C Cervical Disc Prosthesis. The BAGUERA®C implant is an investigational device designed to reconstruct the cervical disc. The goal of this surgery is to restore the height and preserve motion at that spinal level.
(PRNewsfoto/Spineart USA Inc.)
"The BAGUERA®C cervical disc is a modern generation artificial disc and the technique is straightforward compared to other devices I have used. I am excited to continue enrolling more patients and to start collecting outcome data," said Dr. Coric, Principal Investigator at Carolina Neurosurgery and Spine Associates.

Related Keywords

California , United States , Laguna Hills , Switzerland , Jerome Trividic , Drug Administration , Spineart United States Inc , Minimally Invasive Surgery , Motion Preservation , Spineart Usa Inc , கலிஃபோர்னியா , ஒன்றுபட்டது மாநிலங்களில் , லகுனா மலைகள் , சுவிட்சர்லாந்து , குறைந்தபட்சம் ஆக்கிரமிப்பு அறுவை சிகிச்சை , இயக்கம் ப்ரிஸர்வேஶந் ,

© 2025 Vimarsana